PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 205 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $270,000 | -60.8% | 6,962 | -53.7% | 0.38% | -41.9% |
| Q3 2018 | $689,000 | +32.8% | 15,035 | +71.4% | 0.64% | +35.5% |
| Q2 2018 | $519,000 | +6.6% | 8,771 | +22.6% | 0.48% | -6.7% |
| Q1 2018 | $487,000 | +8.2% | 7,157 | +57.1% | 0.51% | +10.9% |
| Q4 2017 | $450,000 | -8.0% | 4,555 | +11.6% | 0.46% | -23.2% |
| Q3 2017 | $489,000 | +134.0% | 4,083 | +70.6% | 0.60% | +89.6% |
| Q2 2017 | $209,000 | – | 2,393 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |